Literature DB >> 19137020

Canonical WNT signalling determines lineage specificity in Wilms tumour.

R Fukuzawa1, M R Anaka, R J Weeks, I M Morison, A E Reeve.   

Abstract

Wilms tumours (WTs) have two distinct types of histology with or without ectopic mesenchymal elements, suggesting that WTs arise from either the mesenchymal or epithelial nephrogenic lineages. Regardless of the presence or absence of CTNNB1 mutations, nuclear accumulation of beta-catenin is often observed in WTs with ectopic mesenchymal elements. Here, we addressed the relationship between the WNT-signalling pathway and lineage in WTs by examining CTNNB1 and WT1 mutations, nuclear accumulation of beta-catenin, tumour histology and gene expression profiles. In addition, we screened for mutations in WTX, which has been proposed to be a negative regulator of the canonical WNT-signalling pathway. Unsupervised clustering analysis identified two classes of tumours: mesenchymal lineage WNT-dependent tumours, and epithelial lineage WNT-independent tumours. In contrast to the mesenchymal lineage specificity of CTNNB1 mutations, WTX mutations were surprisingly observed in both lineages. WTX-mutant WTs with ectopic mesenchymal elements had nuclear accumulation of beta-catenin, upregulation of WNT target genes and an association with CTNNB1 mutations in exon 7 or 8. However, epithelial lineage WTs with WTX mutations had no indications of active WNT signalling, suggesting that the involvement of WTX in the WNT-signalling pathway may be lineage dependent, and that WTX may have an alternative function to its role in the canonical WNT-signalling pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19137020     DOI: 10.1038/onc.2008.455

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  Different incidences of epigenetic but not genetic abnormalities between Wilms tumors in Japanese and Caucasian children.

Authors:  Masayuki Haruta; Yasuhito Arai; Naoki Watanabe; Yuiko Fujiwara; Shohei Honda; Junjiro Ohshima; Fumio Kasai; Hisaya Nakadate; Hiroshi Horie; Hajime Okita; Jun-Ichi Hata; Masahiro Fukuzawa; Yasuhiko Kaneko
Journal:  Cancer Sci       Date:  2012-04-19       Impact factor: 6.716

Review 2.  Wilms tumor--a renal stem cell malignancy?

Authors:  Naomi Pode-Shakked; Benjamin Dekel
Journal:  Pediatr Nephrol       Date:  2011-04-16       Impact factor: 3.714

3.  Molecular characterization of Wilms' tumor from a resource-constrained region of sub-Saharan Africa.

Authors:  Andrew J Murphy; Jason R Axt; Christian de Caestecker; Janene Pierce; Hernan Correa; Erin H Seeley; Richard M Caprioli; Mark W Newton; Mark P de Caestecker; Harold N Lovvorn
Journal:  Int J Cancer       Date:  2012-04-04       Impact factor: 7.396

4.  Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer.

Authors:  Rebeca Sanz-Pamplona; Adriana Lopez-Doriga; Laia Paré-Brunet; Kira Lázaro; Fernando Bellido; M Henar Alonso; Susanna Aussó; Elisabet Guinó; Sergi Beltrán; Francesc Castro-Giner; Marta Gut; Xavier Sanjuan; Adria Closa; David Cordero; Francisco D Morón-Duran; Antonio Soriano; Ramón Salazar; Laura Valle; Victor Moreno
Journal:  Clin Cancer Res       Date:  2015-06-12       Impact factor: 12.531

5.  Wilms tumor chromatin profiles highlight stem cell properties and a renal developmental network.

Authors:  Aviva Presser Aiden; Miguel N Rivera; Esther Rheinbay; Manching Ku; Erik J Coffman; Thanh T Truong; Sara O Vargas; Eric S Lander; Daniel A Haber; Bradley E Bernstein
Journal:  Cell Stem Cell       Date:  2010-06-04       Impact factor: 24.633

Review 6.  Inactivation of X-linked tumor suppressor genes in human cancer.

Authors:  Runhua Liu; Mandy Kain; Lizhong Wang
Journal:  Future Oncol       Date:  2012-04       Impact factor: 3.404

Review 7.  Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene.

Authors:  Vicki Huff
Journal:  Nat Rev Cancer       Date:  2011-01-20       Impact factor: 60.716

8.  Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis.

Authors:  Kristina Becanovic; Mahmoud A Pouladi; Raymond S Lim; Alexandre Kuhn; Paul Pavlidis; Ruth Luthi-Carter; Michael R Hayden; Blair R Leavitt
Journal:  Hum Mol Genet       Date:  2010-01-20       Impact factor: 6.150

9.  Wilms' tumor 1 gene (WT1) is overexpressed and provides an oncogenic function in pediatric nephroblastomas harboring the wild-type WT1.

Authors:  Surasak Sangkhathat; Samornmas Kanngurn; Welawee Chaiyapan; Podchanaporn Gridist; Wanwisa Maneechay
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

10.  Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study.

Authors:  Samantha Gadd; Vicki Huff; Chiang-Ching Huang; E Cristy Ruteshouser; Jeffrey S Dome; Paul E Grundy; Norman Breslow; Lawrence Jennings; Daniel M Green; J Bruce Beckwith; Elizabeth J Perlman
Journal:  Neoplasia       Date:  2012-08       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.